Stockholm, 2 March 2023 (TDI): Sweden will be hosting a High-level meeting on antimicrobial resistance (AMR) on 6-7 March. It will focus on the European Union’s (EU) efforts to abate AMR.
Likewise, it will enable effective treatment of infections with uncomplicated access to new antibiotics. The agenda of the meeting is to sustain easy access to existing and new antibiotics.
While the focus will be on enhancing and evaluating the EU’s continuous efforts at the global level to curb AMR. The experts in the panel will be highlighting measures to stimulate the development of new antibiotics.
The Ministers, State Secretaries, and Directors-General, including heads of European health authorities and participants from international organizations will be sharing the platform for the meetings.
The meeting will be held in presence of the Crown Princess Victoria and Prince Daniel. Dr. Ann Fernholm, renowned journalist and biochemist will be leading and moderating the event.
The first panel discussion will be about how the EU can contribute to a reinforced global response to AMR. It will include Otto Cars as a panelist.
Otto Cars is the Professor Emeritus of Infectious Diseases at Uppsala University, Founder, and Senior Advisor of ReAct (Action on Antibiotic Resistance).
The second-panel discussion will be based on sustainable access to existing and stimulation of the development of new antibiotics.
The topic will be initiated by Swedish Ambassador Dr. Malin Grape. He will be presenting the outputs from the expert session meeting on March 6.
Also read: EU Ministers discuss Energy and Transport Policy challenges
The discussion, moderated by Dr. Ann Fernholm, will include eminent panelists namely, Jakob Forssmed, Minister for Social Affairs and Public Health, Sweden, Azra Herceg, State Secretary responsible for primary health care and public health, Slovenia, Sandra Gallina, Director General, Health, and Food Safety (DG SANTE), European Commission.
Moreover, Dr. Marco Cavaleri, Head of Health Threats and Vaccines Strategy, European Medicines Agency (EMA), and Pierre Delsaux, Director General, of Health Emergency Preparedness and Response Authority (DG HERA), European Commission, will also be part of the discussion.